Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.
O'Hagan
D T
DT
Department of Pharmaceutical Sciences, University of Nottingham, England.
D000284:Administration, Oral; D000818:Animals; D001424:Bacterial Infections / Q000517:prevention & control; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000493:pharmacokinetics; D004337:Drug Carriers; D006801:Humans; D007071:Immunoglobulin A, Secretory / Q000276:immunology; D009061:Mouth Mucosa / Q000276:immunology; D014611:Vaccination / Q000379:methods; D014613:Vaccines, Attenuated / Q000008:administration & dosage* / Q000276:immunology / Q000493:pharmacokinetics; D015164:Vaccines, Inactivated / Q000008:administration & dosage* / Q000276:immunology / Q000493:pharmacokinetics; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology
D001428:Bacterial Vaccines; D004337:Drug Carriers; D007071:Immunoglobulin A, Secretory; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic